Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials

J Glob Antimicrob Resist. 2021 Mar:24:81-82. doi: 10.1016/j.jgar.2020.11.022. Epub 2020 Dec 8.

Authors

Yuki Enoki¹, Yuki Igarashi², Yuki Watabe², Kyoka Honma², Yuto Suzuki², Yukitaka Hayashi², Kana Hiraoka², Kazuaki Taguchi², Kazuaki Matsumoto²

Affiliations

¹ Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan. Electronic address: enoki-yk@pha.keio.ac.jp.
² Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan.

No abstract available

Publication types

Meta-Analysis

MeSH terms

Adenosine Monophosphate / analogs & derivatives*
Adenosine Monophosphate / therapeutic use
Alanine / analogs & derivatives*
Alanine / therapeutic use
COVID-19 Drug Treatment*
Humans
Randomized Controlled Trials as Topic

Substances

remdesivir
Adenosine Monophosphate
Alanine